Copyright
©The Author(s) 2019.
World J Gastroenterol. Apr 7, 2019; 25(13): 1618-1627
Published online Apr 7, 2019. doi: 10.3748/wjg.v25.i13.1618
Published online Apr 7, 2019. doi: 10.3748/wjg.v25.i13.1618
Variable | No. of failure/total patients | P-value |
Distribution of telangiectasias | ||
Distal rectum (within 10 cm from anal verge) | 7/31 | 0.1361 |
Entire rectum +/− sigmoid (more than 10 cm from anal verge) | 7/14 | |
Surface area covered by telangiectasias | ||
Less than 50% | 2/19 | 0.0112 |
More than 50% | 12/26 | |
Presence of fresh blood | ||
No | 3/16 | 0.3201 |
Yes | 11/29 | |
Ulceration | ||
< 1 cm2 | 6/33 | 0.0061 |
> 1 cm2 | 8/12 | |
Gender | ||
Female | 14/40 | 0.3053 |
Male | 0/5 | |
Hypertensive | ||
No | 11/39 | 0.3563 |
Yes | 3/6 | |
Diabetic | ||
No | 11/40 | 0.1663 |
Yes | 3/5 | |
Abdominal surgery | ||
No | 11/33 | 0.8651 |
Yes | 3/12 | |
Acute radiation injury | ||
No | 14/39 | 0.1563 |
Yes | 0/6 | |
Requiring blood transfusions | ||
No | 7/30 | 0.2101 |
Yes | 7/15 | |
Number of APC | ||
1 | 11/33 | 0.8651 |
≥ 2 | 3/12 | |
Age, yr | ||
< 60 | 8/22 | 0.4572 |
≥ 60 | 6/23 | |
BMI at the first treatment of APC, kg/m2 | ||
< 21 | 7/21 | 0.7632 |
≥ 21 | 7/24 | |
Time from the end of radiotherapy to bleeding, mo | ||
< 8 | 6/17 | 0.6372 |
≥ 8 | 8/28 | |
Time from the end of radiotherapy to the first time of APC, mo | ||
< 14 | 8/23 | 0.5862 |
≥ 14 | 6/22 |
Variable | No. of complication/total patients | P-value |
Distribution of telangiectasias | ||
Distal rectum (within 10 cm from anal verge) | 4/31 | 1.0002 |
Entire rectum +/− sigmoid (more than 10 cm from anal verge) | 2/14 | |
Surface area covered by telangiectasias | ||
Less than 50% | 2/19 | 1.0002 |
More than 50% | 4/26 | |
Presence of fresh blood | ||
No | 1/16 | 0.3992 |
Yes | 5/29 | |
Ulceration | ||
< 1 cm2 | 2/33 | 0.0352 |
> 1 cm2 | 4/12 | |
Gender | ||
Female | 5/40 | 0.5292 |
Male | 1/5 | |
Hypertensive | ||
No | 4/39 | 0.3671 |
Yes | 2/6 | |
Diabetic | ||
No | 4/40 | 0.1252 |
Yes | 2/5 | |
Abdominal surgery | ||
No | 6/33 | 0.1712 |
Yes | 0/12 | |
Acute radiation injury | ||
No | 6/39 | 0.6991 |
Yes | 0/6 | |
Requiring blood transfusions | ||
No | 3/30 | 0.3842 |
Yes | 3/15 | |
Number of APC | ||
1 | 5/33 | 1.0002 |
≥ 2 | 1/12 | |
Age, yr | ||
< 60 | 1/22 | 0.1872 |
≥ 60 | 5/23 | |
BMI at the first treatment of APC, kg/m2 | ||
< 21 | 3/21 | 1.0002 |
≥ 21 | 3/24 | |
Time from the end of radiotherapy to bleeding, mo | ||
< 8 | 2/17 | 1.0002 |
≥ 8 | 4/28 | |
Time from the end of radiotherapy to the first time of APC, mo | ||
< 14 | 4/23 | 0.6652 |
≥ 14 | 2/22 |
- Citation: Zhong QH, Liu ZZ, Yuan ZX, Ma TH, Huang XY, Wang HM, Chen DC, Wang JP, Wang L. Efficacy and complications of argon plasma coagulation for hemorrhagic chronic radiation proctitis. World J Gastroenterol 2019; 25(13): 1618-1627
- URL: https://www.wjgnet.com/1007-9327/full/v25/i13/1618.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i13.1618